Summary & Overview
HCPCS G9804: Post-AMI Beta-Blocker Treatment Gap
HCPCS Level II code G9804 documents a gap in post-discharge pharmacologic secondary prevention: the patient was not prescribed at least a 135-day course of beta-blocker therapy within a 180-day measurement window after an acute myocardial infarction (AMI). Nationally, this code is used in quality reporting and claims to flag incomplete beta-blocker coverage after AMI, an area linked to secondary prevention and readmission risk. The code matters because it captures lapses in guideline-concordant pharmacotherapy that payers and quality programs monitor.
The analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code's clinical intent, the service context (post-discharge medication management after AMI), typical sites of service, and how the code fits into quality measurement. The publication summarizes common modifiers and notes when input fields are not provided.
This briefing will help clinicians, billing teams, and policy stakeholders understand the purpose of G9804, where it is applied in the care pathway, and what documentation and measurement implications are associated with recording a post-AMI beta-blocker treatment gap.
Billing Code Overview
HCPCS Level II code G9804 indicates that a patient was not prescribed at least a 135-day treatment within the 180-day measurement interval with beta-blockers post-discharge for AMI. This measure reflects medication management and follow-up after an acute myocardial infarction.
-
Service type: Post-discharge medication management and quality measurement related to secondary prevention after acute myocardial infarction
-
Typical site of service: Hospital inpatient discharge and outpatient follow-up care settings
Clinical & Coding Specifications
Clinical Context
A typical patient is a 62-year-old male admitted to the hospital with an acute myocardial infarction (AMI) who is discharged after stabilization. During the hospitalization the patient underwent cardiac monitoring and medical management but had documented contraindications to beta-blocker therapy (for example, persistent bradycardia or symptomatic hypotension) or beta-blocker therapy was not started. The measure represented by G9804 captures that the patient was not prescribed at least a 135-day supply of beta-blocker therapy within the 180-day post-discharge measurement interval.
Clinical workflow: On discharge the inpatient team documents medication reconciliation and the discharge medication list. Outpatient cardiology or primary care follow-up within 7–30 days reviews secondary prevention medications. Pharmacy fills and outpatient prescription records are reviewed to determine whether at least a 135-day supply of a beta-blocker was prescribed within 180 days after discharge. If a patient has a documented clinical contraindication to beta-blockers, this is noted in the chart and the measure is coded accordingly. Typical sites of service include inpatient hospital (acute care) for the index AMI admission and outpatient offices or clinics (cardiology, primary care) for follow-up and medication management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when atypical work or increased complexity related to discharge planning or medication reconciliation requires substantial additional physician work. |
23 | Unusual anesthesia | Rarely applicable; only used if anesthesia was provided and was unusual during any concomitant procedure tied to the admission. |
52 | Reduced services | Use when a related service was partially reduced or not completed (e.g., partial outpatient medication visit). |
53 | Discontinued procedure | Use if a planned procedure related to AMI care was started but discontinued for clinical reasons. |
54 | Surgical care only | Use when only the surgical component of a related procedure was performed; rarely used for medical discharge coding. |
55 | Postoperative management only | Use when only postoperative follow-up was billed by another provider managing medication changes post-discharge. |
56 | Preoperative management only | Use when another provider billed preoperative management during the index admission. |
62 | Two surgeons | Use only if two surgeons were required for a related surgical intervention during the admission. |
AS | Physician assistant, nurse practitioner, or clinical nurse specialist services for assistant at surgery | Use when an advanced practice provider assisted in a procedure during the admission. |
CO | Temporary public health emergency exemption | Use when the claim relates to a designated public health emergency exemption (payor-specific). |
CQ | Service furnished by a rehabilitation agency (in lieu of home health) | Use if a rehabilitation agency provided services relevant to post-AMI care. |
FX | Hardware failure | Use if a procedure required revision due to hardware failure during follow-up care. |
FY | Item replacement from warranty | Use if equipment replacement under warranty was provided during follow-up care. |
QK | Medical direction of two, three, or four concurrent anesthesia procedures | Use if anesthesia direction was billed for concurrent cases. |
QX | CRNA service with medical direction | Use when a CRNA furnished anesthesia under medical direction during an operative procedure associated with the admission. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
207R00000X | Cardiology | Inpatient and outpatient cardiologists manage secondary prevention medications post-AMI. |
207L00000X | Interventional Cardiology | Often involved if the AMI required PCI; participates in discharge medication decisions. |
207Q00000X | Family Medicine | Primary care physicians coordinate outpatient medication management and follow-up. |
208D00000X | Internal Medicine | Hospitalists and internists manage inpatient care and discharge prescriptions. |
363L00000X | Nurse Practitioner | Advanced practice providers commonly manage follow-up medication reconciliation and prescriptions. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
I21.9 | Acute myocardial infarction, unspecified | Represents AMI as the index event for which beta-blocker therapy is a standard component of secondary prevention. |
I21.3 | ST elevation (STEMI) myocardial infarction of other sites of posterior wall | A specific AMI subtype where beta-blockers are commonly indicated post-discharge. |
I21.4 | Non-ST elevation (NSTEMI) myocardial infarction | NSTEMI is an AMI subtype; beta-blocker prescribing is evaluated during the post-discharge interval. |
I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | Chronic coronary disease status relevant to ongoing beta-blocker therapy decisions. |
I50.9 | Heart failure, unspecified | Heart failure may modify beta-blocker choice or dosing and is relevant when assessing contraindications or treatment plans. |
Z79.899 | Other long term (current) drug therapy | Used to document ongoing medication therapy; relevant when assessing prior beta-blocker use. |
R00.0 | Tachycardia, unspecified | Baseline arrhythmias or rate issues that influence beta-blocker initiation or avoidance. |
R00.1 | Bradycardia, unspecified | Bradycardia is a potential contraindication to beta-blocker therapy and explains omission of prescriptions. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
99238 | Hospital discharge day management; 30 minutes or less | Used by the discharging physician to document discharge and the medication reconciliation that would include beta-blocker prescriptions. |
99496 | Transitional care management services with high complexity medical decision making (7–14 days) | Used for early post-discharge follow-up that includes medication management and reconciliation relevant to beta-blocker prescribing. |
93000 | Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | Performed during index admission and sometimes at follow-up to assess cardiac status influencing beta-blocker use. |
92928 | Percutaneous coronary intervention (PCI) with stent; single vessel | Commonly performed during AMI admission; interventional procedures influence secondary prevention medication plans. |
99490 | Chronic care management services, at least 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month | Ongoing outpatient management that may include ensuring continuity of beta-blocker therapy within the measurement interval. |